Projects per year
Personal profile
Education
- 1996 Dr.rer.nat., Institute of Pharmacy, University of Regensburg, Germany
- 1987 Master, Institute of Pharmacy, National Defense Medical Center
- 1985 Bachelor, School of Pharmacy, National Defense Medical Center
Experience
- 2018- Professor, Master Program in Graduate Institute of Cancer Biology and Drug Discovery, Taipei Medical University
- 2018- Professor, Graduate Institute of Nanomedicine and Medical Engineering, Taipei Medical University
- 2014-2018 Professor, Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University.
Awards
- Editorial Board:
- International Journal of Advanced Chemistry (IJAC)
- International Journal of Organic Chemistry
- Der Pharma Chemica
- Journal of Chemical Science and Technology
- Advances in Organic Chemistry (AOC)
- Journal of Bone Marrow and Stem Cell Research
- Journal of Natural Products Research Updates
- Innovational: Journal of Chemistry (IJChem)
- International Journal of Biological Instrumentation
- Asian Council of Science
- Editorial Advisory Board:
- The Open Cancer Journal (ISSN: 1874-0790)
- Recent Patent Reviews on Anti-cancer Drug Discovery
- Outstanding reviewer:
- Outstanding reviewer: Bioorganic & Medicinal Chemistry
- Outstanding reviewer: European Journal of Medicinal Chemistry
Research Interests
- New drugs discovery and development
- Medicinal chemistry
- Discovery of novel anticancer drugs
- Discovery of novel anti-inflammatory drugs
URL
Fingerprint Dive into the research topics where Hsu-Shan Huang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 7 Similar Profiles
Anthraquinones
Medicine & Life Sciences
Derivatives
Chemical Compounds
Telomerase
Medicine & Life Sciences
Cells
Chemical Compounds
Anthracenes
Medicine & Life Sciences
Anthralin
Medicine & Life Sciences
Antineoplastic Agents
Medicine & Life Sciences
Cytotoxicity
Chemical Compounds
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2014 2020
利用人工智能與機器學習模式開發新型多靶點抗癌藥物的新發展策略
8/1/19 → 7/1/20
Project: A - Government Institution › b - Ministry of Science and Technology
基於片段的藥物探索方法開發新一類抗癌標靶小分子激酶抑制劑(2/2)
8/1/18 → 7/1/19
Project: A - Government Institution › b - Ministry of Science and Technology
基於片段的藥物探索方法開發新一類抗癌標靶小分子激酶抑制劑(1/2)
8/1/17 → 7/31/18
Project: A - Government Institution › b - Ministry of Science and Technology
Development of Novel Tetracyclic and Heterocyclic Dual Topoisomerases Inhibitors as Anticancer Agents( II )
8/1/16 → 7/31/17
Project: A - Government Institution › b - Ministry of Science and Technology
Development of Novel Tetracyclic and Heterocyclic Dual Topoisomerases Inhibitors as Anticancer Agents( I )
8/1/15 → 7/31/16
Project: A - Government Institution › b - Ministry of Science and Technology
Research Output 1988 2019
A novel multi-target small molecule, LCC-09, inhibits stemness and therapy-resistant phenotypes of glioblastoma cells by increasing MIR-34a and deregulating the DRD4/AKT/MTOR signaling axis
Wen, Y. T., Wu, A. T., Bamodu, O. A., Wei, L., Lin, C. M., Yen, Y., Chao, T. Y., Mukhopadhyay, D., Hsiao, M. & Huang, H. S., Oct 1 2019, In : Cancers. 11, 10, 1442.Research output: Contribution to journal › Article
Open Access
temozolomide
Glioblastoma
Phenotype
Glioma
Stem Cells
A novel salicylanilide derivative induces autophagy cell death in castration-resistant prostate cancer via ER stress-activated PERK signaling pathway
Hsieh, C-L., Huang, H-S., Chen, K-C., Saka, T., Chiang, C-Y., Chung, L. W. K. & Sung, S-Y., Sep 17 2019, In : Molecular Cancer Therapeutics.Research output: Contribution to journal › Article
Castration
Autophagy
Prostatic Neoplasms
Cell Death
Osteogenesis
1
Citation
(Scopus)
Anti-inflammatory and anti-osteoarthritis effects of Cm-02 and Ck-02
Ho, Y. J., Lu, J. W., Ho, L. J., Lai, J. H., Huang, H. S., Lee, C. C., Lin, T. Y., Lien, S. B., Lin, L. C., Chen, L. W., Gong, Z., Shen, M. C. & Liu, F. C., Sep 10 2019, In : Biochemical and Biophysical Research Communications. 517, 1, p. 155-163 9 p.Research output: Contribution to journal › Article
Cartilage
Osteoarthritis
Chondrocytes
Anti-Inflammatory Agents
Chemical activation
Design and Evaluation of PEGylated Liposomal Formulation of a Novel Multikinase Inhibitor for Enhanced Chemosensitivity and Inhibition of Metastatic Pancreatic Ductal Adenocarcinoma
Madamsetty, V. S., Pal, K., Dutta, S. K., Wang, E., Thompson, J. R., Banerjee, R. K., Caulfield, T. R., Mody, K., Yen, Y., Mukhopadhyay, D. & Huang, H-S., Oct 4 2019, In : Bioconjugate Chemistry.Research output: Contribution to journal › Article
Epidermal Growth Factor Receptor
gemcitabine
Adenocarcinoma
Chemotherapy
Protein-Tyrosine Kinases
A new niclosamide derivatives-B17 can inhibit urological cancers growth through apoptosis-related pathway
Wu, C-L., Chen, C-L., Huang, H-S. & Yu, D-S., Jun 28 2018, In : Cancer Medicine.Research output: Contribution to journal › Article
Niclosamide
Urologic Neoplasms
Apoptosis
Growth
Control Groups